Accepting new patients
Prof. Dr.
Dr Spyridon (Spyros) Gennatas
Oncology
- 🇬🇧
- 🌍
- GP consultation
- Annual physical exam
- Vaccination administration
- Minor procedure (skin)
About Dr Spyridon (Spyros) Gennatas
Dr Spyros Gennatas is a Consultant Medical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust, specialising in thoracic cancers including lung cancer (small cell and all non-small cell subtypes), mesothelioma, and thymic epithelial tumours. He completed his specialty training at the Royal Marsden Hospital and holds a PhD from Imperial College London, where his research focused on the molecular genetics of thymic epithelial tumours. He has published widely in peer-reviewed journals and has presented his work at major international conferences, including in the areas of molecular oncology, cancer genomics, COVID-19 and cancer care, and quality of life research. His research interests include the development of novel therapeutic agents for thoracic cancers, the identification of predictive and prognostic biomarkers, and the advancement of personalised cancer care. He also has a strong interest in rare tumours, with ongoing clinical and academic work focused on improving outcomes for patients with rare malignancies such as thymic epithelial tumours and mesothelioma. He is further engaged in initiatives to promote equity and diversity in clinical trial recruitment and real-world research. Dr Gennatas is an invited Clinical Expert to the National Institute for Health and Care Excellence (NICE) and is active in international organisations, including the Rare Tumours Committee of the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO), where he contributes to the Sarcoma and Rare Cancers Scientific Committee. He remains very actively involved in postgraduate teaching and mentorship.
"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."
Credentials & verification
Medical license
Organización Médica Colegial de España (OMC) ·
#-650383
Valid until 2028-12-31
Verify with issuerBoard certification
European Board of Oncology
#EB-A1F5A480
Renewal due 2024
Verify with issuerMalpractice cover
AXA Healthcare Liability
5,000,000 EUR
Valid until 2026-12-31
No claims on file
Education & training
-
2003–2009
MD · Medicine and Surgery
Universidad de Navarra
-
2009–2013
Residency · Oncology
Universitat de Barcelona
Career & appointments
-
2013-09–2014-08
Junior consultant
Universidad de Navarra Teaching Hospital — Oncology
Procedures & conditions
| Procedure | Code | Lifetime volume |
|---|---|---|
| GP consultation | 99213 |
391 |
| Annual physical exam | 99395 |
2,105 |
| Vaccination administration | 90471 |
1,377 |
| Minor procedure (skin) | 17110 |
1,222 |
Patient reviews
See all 3"Very thorough first visit — explained every step. Booking was easy and the staff were welcoming."
"Took time to listen and reviewed all my previous results. I would absolutely recommend."
"Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent."
Recognition & press
Awards
- Top-rated Oncology — — EuroClinics Patient Choice · 2025 regional
- Excellence in Patient Care — National Society · 2024 national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2014
- national college of family doctors — Member · since 2014
- European Union of Medical Specialists (UEMS) — Member · since 2014
Your consultation, step by step
- 1 Choose a slot
- 2 Brief pre-consult form
- 3 Consultation
- 4 Follow-up note & plan
Services & pricing
New patient consultation (60m)
Follow-up consultation (30m)
Vaccination administration
Minor procedure (skin)
Insurance compatibility
For international patients
Multilingual care
Coordinator: Patient liaison · spyirdon.gennatas@euroclinics.example. Care delivered in English · Greek.
Travel & transfer
Aftercare worldwide
Coordinated follow-up by request.
Research & publications
h-index: 4 · i10: 4
Selected publications
-
Long-term follow-up of Oncology across
DOI: 10.8120/euroclin.2026.0 · cited by 15
-
Validation of clinical scoring in Oncology
DOI: 10.4942/euroclin.2025.1 · cited by 69
Show full research record
Invited talks
- Practical updates in Oncology · European Annual Congress (Oncology) · Vienna · 2024
- Single-centre experience in Oncology · National Society Meeting · · 2023
Articles by Dr Spyridon (Spyros) Gennatas
Frequently asked
01. Do you accept new patients?
Dr Spyridon (Spyros) Gennatas is currently accepting new patients. Use the booking module to choose a slot.
02. Which languages can I be seen in?
Consultations are available in English, Greek.
03. Is the consultation in-person or online?
Most services are offered both in-clinic and via telemedicine. Each service card above marks its modalities.
04. Do you accept my insurance?
In-network with major international insurers (Allianz Worldwide, AXA Global, BUPA Global and others). Use the "Verify my insurance" button to confirm your plan.
05. What is the cancellation policy?
Free cancellation up to 24 hours before your slot. Last-minute cancellations may incur a small administrative fee.
06. How is my health data protected?
All records are stored on EU servers, field-level encrypted, and GDPR compliant. Data is never shared with third parties without your explicit consent.
Book Dr Spyridon (Spyros) Gennatas
Similar Oncology specialists
Other verified specialists you may want to compare.